Trulieve Cannabis Corp. is a vertically integrated medical cannabis multi-state operator in the U.S. It cultivates, processes and sells branded cannabis products, primarily through its own retail dispensaries, which generate about 95% of revenue. It has medical marijuana operations in Florida, Georgia, Pennsylvania and West Virginia, with expansion planned in Texas. The company runs 208 dispensaries and 3.5 million square feet of cultivation and processing capacity.
In June 2026 it deconsolidated Harvest's mixed medical and adult-use operations and now holds an equity investment in Harvest. Following federal rescheduling of state-licensed medical marijuana to Schedule III, Trulieve has received DEA registrations. It is no longer subject to the 280E tax and has redomiciled from British Columbia to Delaware. It is listed on the NYSE under TRLV.
Its product portfolio includes in-house brands such as Modern Flower and Roll One. It also holds a perpetual license for Alien Labs and Connected branded products in Florida and Texas. Updated
Retail investors in r/options are making an unusual bet on AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), and the activity is hard to ignore. The post reflects the speculative tone common in options-focused…
The cannabis sector is one which many may have rightly described as a bubble seven or eight years ago. That’s because it was. Valuations in this sector got to obscene levels, with…
Trulieve Cannabis Corp. is a vertically integrated medical cannabis multi-state operator in the U.S. It cultivates, processes and sells branded cannabis products, primarily through its own retail dispensaries, which generate about 95% of revenue.
